Jean Elwing

3.2k total citations · 1 hit paper
60 papers, 1.5k citations indexed

About

Jean Elwing is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Jean Elwing has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 16 papers in Cardiology and Cardiovascular Medicine and 11 papers in Surgery. Recurrent topics in Jean Elwing's work include Pulmonary Hypertension Research and Treatments (44 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Vascular Anomalies and Treatments (9 papers). Jean Elwing is often cited by papers focused on Pulmonary Hypertension Research and Treatments (44 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Vascular Anomalies and Treatments (9 papers). Jean Elwing collaborates with scholars based in United States, Italy and United Kingdom. Jean Elwing's co-authors include Francis X. McCormack, John J. Bissler, Vincent J. Schmithorst, Alan S. Brody, Lisa R. Young, Tal Laor, Jennifer Leonard, Gail Chuck, Judy A. Bean and Shelia Salisbury and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Jean Elwing

52 papers receiving 1.5k citations

Hit Papers

Sirolimus for Angiomyolipoma in Tuberous Sclerosis Comple... 2008 2026 2014 2020 2008 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
    2008 888 citations Francis X. McCormack, Jean Elwing et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Elwing United States 12 795 766 348 311 295 60 1.5k
A. Morganti United States 13 1.7k 2.1× 321 0.4× 221 0.6× 622 2.0× 507 1.7× 26 2.5k
Matthieu Canuet France 15 665 0.8× 165 0.2× 130 0.4× 216 0.7× 55 0.2× 48 934
Takaki Akamine Japan 27 969 1.2× 344 0.4× 180 0.5× 39 0.1× 1.2k 4.0× 94 2.0k
Yoshihiko Taniguchi Japan 19 612 0.8× 103 0.1× 146 0.4× 57 0.2× 705 2.4× 103 1.2k
Vasile Foris Austria 18 786 1.0× 56 0.1× 162 0.5× 341 1.1× 136 0.5× 54 1.1k
Esther González-López Spain 17 182 0.2× 309 0.4× 1.8k 5.3× 689 2.2× 561 1.9× 44 2.2k
Jolanta Dadonienė Lithuania 14 929 1.2× 346 0.5× 115 0.3× 114 0.4× 46 0.2× 50 1.5k
Shigeo Hisamori Japan 23 719 0.9× 271 0.4× 401 1.2× 59 0.2× 689 2.3× 69 1.9k
G Ghilardi Italy 17 230 0.3× 73 0.1× 308 0.9× 147 0.5× 340 1.2× 78 1.1k
Stela Bulimbašić Croatia 17 688 0.9× 130 0.2× 526 1.5× 49 0.2× 85 0.3× 57 926

Countries citing papers authored by Jean Elwing

Since Specialization
Citations

This map shows the geographic impact of Jean Elwing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Elwing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Elwing more than expected).

Fields of papers citing papers by Jean Elwing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Elwing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Elwing. The network helps show where Jean Elwing may publish in the future.

Co-authorship network of co-authors of Jean Elwing

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Elwing. A scholar is included among the top collaborators of Jean Elwing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Elwing. Jean Elwing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narayanan, S., et al.. (2025). Fibrosing Mediastinitis. 14(1).
2.
Howard, Luke, Jean Elwing, Catarina Fernandes, et al.. (2025). 10-year Data on Oral Selexipag: Long-Term Survival, Safety, and Dosing Insights in Pulmonary Arterial Hypertension (PAH) from the GRIPHON Study and Its Open-Label Extension (OLE). The Journal of Heart and Lung Transplantation. 44(4). S75–S76.
3.
Jose, Arun, Alexander R. Opotowsky, Thomas J. Glorioso, et al.. (2024). Association Between Cardiopulmonary Hemodynamics and Morality in Veterans With Liver Cirrhosis. A3135–A3135.
4.
Jose, Arun, Alexander R. Opotowsky, Thomas J. Glorioso, et al.. (2024). Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study. Journal of the American Heart Association. 13(8). e033847–e033847. 4 indexed citations
5.
White, R. James, Karim El‐Kersh, Stephan Rosenkranz, et al.. (2024). Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities. CHEST Journal. 167(6). 1746–1758. 1 indexed citations
6.
7.
Jose, Arun, Antolin S. Flores, Nicholas J. Douville, et al.. (2024). Association of Cardiopulmonary Hemodynamics and Outcomes in Pulmonary Hypertension Following Kidney Transplantation. CHEST Journal. 166(6). 1499–1510. 1 indexed citations
8.
Jose, Arun, et al.. (2023). Socioeconomic and Social Determinants of Health: Effects on Pulmonary Arterial Hypertension Care. Advances in Pulmonary Hypertension. 22(2). 111–117.
9.
Forfia, Paul R., Raymond L. Benza, Michele D’Alto, et al.. (2023). The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertension. Pulmonary Circulation. 13(2). e12240–e12240. 3 indexed citations
10.
McConnell, John W., et al.. (2023). Gaps in the Care of Pulmonary Hypertension: A Cross‐Sectional Patient Simulation Study Among Practicing Cardiologists and Pulmonologists. Journal of the American Heart Association. 12(2). e026413–e026413. 4 indexed citations
11.
Franco, Verónica, Vijay Balasubramanian, Ronald Zolty, et al.. (2023). Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil. Respiratory Medicine. 218. 107374–107374. 3 indexed citations
12.
Nadipelli, Vijay R., et al.. (2022). Social determinants of health in pulmonary arterial hypertension patients in the United States: Clinician perspective and health policy implications. Pulmonary Circulation. 12(3). e12111–e12111. 15 indexed citations
13.
Sahay, Sandeep, Oksana A. Shlobin, Francisco Rafael Martins Soto, et al.. (2022). Effects of COVID-19 pandemic on the management of pulmonary hypertension. Respiratory Medicine. 206. 107061–107061. 3 indexed citations
14.
Nathan, Steven D., Victor F. Tapson, Jean Elwing, et al.. (2021). Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial. American Journal of Respiratory and Critical Care Medicine. 205(2). 198–207. 44 indexed citations
15.
Alkhawam, Hassan, et al.. (2019). SLOW AND STEADY WINS THE RACE: MANAGEMENT OF PERICARDIAL TAMPONADE IN THE SETTING OF PULMONARY HYPERTENSION. Journal of the American College of Cardiology. 73(9). 2843–2843. 1 indexed citations
16.
Jose, Arun, et al.. (2019). Cardiac magnetic resonance imaging as a prognostic biomarker in treatment-naïve pulmonary hypertension. European Journal of Radiology. 123. 108784–108784. 5 indexed citations
17.
Elwing, Jean, Anjali Vaidya, & William R. Auger. (2018). Chronic Thromboembolic Pulmonary Hypertension. Clinics in Chest Medicine. 39(3). 605–620. 20 indexed citations
18.
19.
Girnita, Diana M., et al.. (2016). A Unique Presentation of Anti-RNA Polymerase III Positive Systemic Sclerosis Sine Scleroderma. SHILAP Revista de lepidopterología. 2016. 1–4. 1 indexed citations
20.
Panos, Ralph J., et al.. (2009). DOES PULMONARY HYPERTENSION IDENTIFIED BY ECHOCARDIOGRAPHY PROMPT FURTHER EVALUATION?. CHEST Journal. 136(4). 59S–59S. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Morganti Breakdown of academic impact, for papers by Matthieu Canuet Breakdown of academic impact, for papers by Takaki Akamine Breakdown of academic impact, for papers by Yoshihiko Taniguchi Breakdown of academic impact, for papers by Vasile Foris Breakdown of academic impact, for papers by Esther González-López Breakdown of academic impact, for papers by Jolanta Dadonienė Breakdown of academic impact, for papers by Shigeo Hisamori Breakdown of academic impact, for papers by G Ghilardi Breakdown of academic impact, for papers by Stela Bulimbašić
Rankless by CCL
2026